Retrospective evaluation of acute hyperkalemia of unknown origin during general anesthesia in dogs.

OBJECTIVE: To report and characterize cases of acute hyperkalemia of unknown origin in dogs under anesthesia. STUDY DESIGN: Multicentric retrospective clinical study. ANIMALS: Medical records of 19 client-owned dogs that developed acute hyperkalemia during anesthesia. METHODS: Anesthetic records of dogs developing acute hyperkalemia from January 2015 to December 2022 were evaluated. Data collected included demographics, duration of anesthesia until the episode, electrolytes and blood gas measurements, electrocardiogram (ECG) abnormalities, drugs used as part of the anesthetic protocol, hyperkalemia treatment and outcome. RESULTS: A total of 13 cases met the inclusion criteria with documented acute hyperkalemia with no apparent underlying cause during anesthesia. Dogs were [mean ± standard deviation (range)] 6.5 ± 5.0 (3-10) years old and weighed 18.0 ± 14.3 (5.1-40.0) kg. All dogs were administered dexmedetomidine and an opioid as part of the premedication. All dogs had inhalation anesthesia of >60 minutes' duration. The first clinical sign was bradycardia that was minimally responsive to anticholinergic administration and was often accompanied by moderate/severe hypotension. These signs were rapidly followed by ECG changes compatible with hyperkalemia and/or cardiac arrest. Rapid identification and treatment for hyperkalemia, with or without dexmedetomidine reversal, resulted in survival of 12 dogs and one fatality. CONCLUSIONS AND CLINICAL RELEVANCE: Unknown origin hyperkalemia is a life-threatening complication that can occur during general anesthesia. In healthy dogs, preanesthetic administration of dexmedetomidine in association with an opioid and followed by inhalation anesthesia of more than 1 hour duration may predispose to this complication. A sudden decrease in heart rate >90 minutes after dexmedetomidine administration, or ECG changes, may warrant measurement of blood potassium concentrations.

Some cardiopulmonary effects of capnoperitoneum in anesthetized guinea pigs (Cavia porcellus): spontaneous ventilation versus intubation and mechanical ventilation.

OBJECTIVE: To compare cardiopulmonary variables and blood gas analytes in guinea pigs (Cavia porcellus) during anesthesia with and without abdominal carbon dioxide (CO2) insufflation at intra-abdominal pressures (IAPs) 4 and 6 mmHg, with and without endotracheal intubation. STUDY DESIGN: Prospective experimental trial. ANIMALS: A total of six intact female Hartley guinea pigs. METHODS: A crossover study with sequence randomization for IAP and intubation status was used. The animals were sedated with intramuscular midazolam (1.5 mg kg-1) and buprenorphine (0.2 mg kg-1) and anesthetized with isoflurane, and an abdominal catheter was inserted for CO2 insufflation. Animals with endotracheal intubation were mechanically ventilated and animals maintained using a facemask breathed spontaneously. After 15 minutes of insufflation, the following variables were obtained at each IAP: pulse rate, respiratory rate, rectal temperature, oxygen saturation, end-tidal CO2 (intubated only), peak inspiratory pressure (intubated only), noninvasive blood pressure and blood gas and electrolyte values, with a rest period of 5 minutes between consecutive IAPs. After 4 weeks, the procedure was repeated with the guinea pigs assigned the opposite intubation status. RESULTS: Intubated guinea pigs had significantly higher pH and lower partial pressure of CO2 in cranial vena cava blood (PvCO2) than nonintubated guinea pigs. An IAP of 6 mmHg resulted in a significantly higher PvCO2 (65.9 ± 19.0 mmHg; 8.8 ± 2.5 kPa) than at 0 (53.2 ± 17.2 mmHg; 7.1 ± 2.3 kPa) and 4 mmHg (52.6 ± 10.8 mmHg; 7.01 ± 1.4 kPa), mean ± standard deviation, with intubated and nonintubated animals combined. CONCLUSIONS AND CLINICAL RELEVANCE: Although the oral anatomy of guinea pigs makes endotracheal intubation difficult, capnoperitoneum during anesthesia induces marked hypercapnia in the absence of mechanical ventilation. An IAP of 4 mmHg should be further evaluated for laparoscopic procedures in guinea pigs because hypercapnia may be less severe than with 6 mmHg.

Effect of pneumoperitoneum on gastrointestinal motility, pain behaviors, and stress biomarkers in guinea pigs (Cavia porcellus).

OBJECTIVE: To compare stress markers, gastrointestinal motility, and behavioral indicators of pain between guinea pigs undergoing pneumoperitoneum with carbon dioxide (CO2) and control guinea pigs. ANIMALS: Fourteen 4- to 5-month-old intact female Hartley guinea pigs. PROCEDURES: Guinea pigs were randomized to receive insufflation or serve as controls (anesthesia and abdominal catheter placement without insufflation), with 7 animals/group. Insufflated animals underwent 6 mm Hg of CO2 pneumoperitoneum for 30 minutes. Afterward, results for vital signs, blood glucose, fecal cortisol, appetite, fecal output, and behaviors (via video recording) were compared between the 2 groups. RESULTS: There was no difference between groups and over time for body temperature, heart rate, fecal output in grams, pellets consumed, blood glucose, and fecal cortisol. Guinea pigs that underwent insufflation had significantly more fecal pellets at 36 hours after the procedure. Several behaviors were expressed similarly between groups and over time, such as body turns, incomplete movement, rearing, lying down, drinking, and hiding. Coprophagy occurred less often in the insufflated versus noninsufflated group at 12 h postprocedure but was similar between groups at other time points. At 60 hours after the procedure, insufflated animals spent less time squinting compared to noninsufflated animals. Other behaviors were differentially expressed over time but not between treatments. CLINICAL RELEVANCE: Overall, there were no major differences in appetite, stress markers, and behaviors between insufflated and control guinea pigs. CO2 insufflation did not appear to cause undue pain or stress in guinea pigs and may be a reasonable technique to use during laparoscopy.

Description and validation of a new descriptive and multiparametric numeric rating scale to assess sedation in cats.

The objective of this study was to design and assess the validity and reliability of a new feline multiparametric sedation scale (FMSS). A total of 89 household cats were recruited, enabling a total of 534 sedation assessments. Every assessment was performed by 3 blinded observers with varying expertise levels (Level 1: Student; Level 2: RVT; Level 3: ACVAA diplomate or senior resident). For comparison purposes, a visual analogue scale (VAS) and a Simple Qualitative Scale (SQS) were also used concurrently, with the VAS considered the gold standard. The new scale had excellent inter-observer agreement among experience groups with weighted Kappa scores of 0.84 (Levels 1 versus 2), 0.82 (Levels 2 versus 3), and 0.84 (Levels 1 versus 3), with P < 0.0001 for all comparisons. There was a high degree of association between FMSS and VAS (r = 0.90, P < 0.0001) and between FMSS and SQS (r = 0.89, P < 0.0001). Final FMSS numerical values were paired with levels of sedation with None = 0 (0 to 5), Mild = 4 (1 to 7), Moderate = 6 (2 to 10), and Profound = 12 (7 to 12); furthermore, differences were detected between pre- and post-sedation evaluations (P = 0.001). This scale demonstrated internal consistency and sensitivity even when evaluating drugs or doses with minimal sedative effects and there was very strong interrater reliability, independent of experience level. Based on this clinical study, we concluded that the use of this sedation scale is appropriate when objective numerical sedation quantification is required, in either a clinical or research setting.

Description et validation d'une nouvelle échelle d'évaluation numérique descriptive et multiparamétrique pour évaluer la sédation chez le chat. L'objectif de cette étude était de concevoir et d'évaluer la validité et la fiabilité d'une nouvelle échelle de sédation multiparamétrique féline (FMSS). Un total de 89 chats domestiques a été recruté, permettant un total de 534 évaluations de sédation. Chaque évaluation a été effectuée par trois observateurs en aveugle avec différents niveaux d'expertise (Niveau 1 : étudiant; Niveau 2 : RVT; Niveau 3 : diplomate de l'ACVAA ou résident senior). À des fins de comparaison, une échelle visuelle analogique (VAS) et une échelle qualitative simple (SQS) ont également été utilisées simultanément, VAS étant considérée comme l'étalon. La nouvelle échelle présentait un excellent accord inter-observateurs parmi les groupes d'expérience avec des scores Kappa pondérés de 0,84 (niveaux 1 versus 2), 0,82 (niveaux 2 versus 3) et 0,84 (niveaux 1 versus 3), avec P < 0,0001 pour toutes les comparaisons. Il y avait un degré élevé d'association entre FMSS et VAS (r = 0,90, P < 0,0001) et entre FMSS et SQS (r = 0,89, P < 0,0001). Les valeurs numériques FMSS finales ont été appariées avec les niveaux de sédation avec Aucun = 0 (0 à 5), Léger = 4 (1 à 7), Modéré = 6 (2 à 10) et Profond = 12 (7 à 12); en outre, des différences ont été détectées entre les évaluations pré- et post-sédation (P = 0,001). Cette échelle a démontré une cohérence interne et une sensibilité même lors de l'évaluation de médicaments ou de doses avec des effets sédatifs minimes et il y avait une très forte fiabilité inter-évaluateur, indépendamment du niveau d'expérience. Sur la base de cette étude clinique, nous avons conclu que l'utilisation de cette échelle de sédation est appropriée lorsqu'une quantification numérique objective de la sédation est requise, dans un cadre clinique ou de recherche.(Traduit par Dr Serge Messier).

Use of intravenous lidocaine to treat dexmedetomidine-induced bradycardia in sedated and anesthetized dogs.

OBJECTIVE: To assess cardiopulmonary function in sedated and anesthetized dogs administered intravenous (IV) dexmedetomidine and subsequently administered IV lidocaine to treat dexmedetomidine-induced bradycardia. STUDY DESIGN: Prospective, randomized, crossover experimental trial. ANIMALS: A total of six purpose-bred female Beagle dogs, weighing 9.1 ± 0.6 kg (mean ± standard deviation). METHODS: Dogs were randomly assigned to one of three treatments: dexmedetomidine (10 µg kg-1 IV) administered to conscious (treatments SED1 and SED2) or isoflurane-anesthetized dogs (end-tidal isoflurane concentration 1.19 ± 0.04%; treatment ISO). After 30 minutes, a lidocaine bolus (2 mg kg-1) IV was administered in treatments SED1 and ISO, followed 20 minutes later by a second bolus (2 mg kg-1) and a 30 minute lidocaine constant rate infusion (L-CRI) at 50 (SED1) or 100 µg kg-1 minute-1 (ISO). In SED2, lidocaine bolus and L-CRI (50 µg kg-1 minute-1) were administered 5 minutes after dexmedetomidine. Cardiopulmonary measurements were obtained after dexmedetomidine, after lidocaine bolus, during L-CRI and 30 minutes after discontinuing L-CRI. A mixed linear model was used for comparisons within treatments (p < 0.05). RESULTS: When administered after a bolus of dexmedetomidine, lidocaine bolus and L-CRI significantly increased heart rate and cardiac index, decreased mean blood pressure, systemic vascular resistance index and oxygen extraction ratio, and did not affect stroke volume index in all treatments. CONCLUSION AND CLINICAL RELEVANCE: Lidocaine was an effective treatment for dexmedetomidine-induced bradycardia in healthy research dogs.

First report of nt230(del4) mutation in the MDR1 gene in German Shepherds in Southern Brazil / Primeiro relato da mutação nt230(del4) no gene MDR1 em Pastores Alemães no Sul do Brasil

ABSTRACT: The P-glycoprotein (P-gp) is a transmembrane protein encoded by the MDR1 gene that functions as a biological barrier by extruding toxins and xenobiotics out of cells. The MDR1 gene can carry a mutation called nt230(del4), which is a deletion of four base pairs resulting in the formation of a non-functional protein that may predispose to severe toxicosis, as observed in dogs with sensitivity to ivermectin. Several breeds have been described as carriers of the mutation, including German Shepherds (GS). However, the presence of the mutant allele in this breed has not been described in Brazil. This study aimed to determine the genotypic and allelic frequency of the nt230(del4) mutation in the MDR1 gene in GS from Southern Brazil. Blood samples were collected from 79 GS in the state of Rio Grande do Sul and genotype for the MDR1 gene was performed. Seventy-eight (98.7%) dogs were dominant homozygous genotype (wild) and one (1.3%) was heterozygous. This study showed that there is a low frequency (0.6%) of the mutant allele while the frequency of the wild allele is high (99.4%) in this specific population. This is the first report of the presence of the nt230(del4) mutation in the MDR1 gene in GS in Brazil. This information is important for breeders to prevent dissemination of the mutant allele in the national breeding population and international exchange of animals for breeding; for owners and veterinarians to be aware when dispensing and administering medications for GS dogs in Brazil.

RESUMO: A Glicoproteína-P é uma proteína transmembrana codificada pelo gene MDR1 que atua como uma barreira fisiológica através da extrusão de toxinas e xenobióticos para fora das células. O gene MDR1 pode carregar uma mutação chamada nt230(del4) que é uma deleção de quatro pares de bases, resultando na formação de uma proteína não-funcional que pode predispor à toxicoses graves, como as observadas em cães sensíveis à ivermectina. Diversas raças de cães foram descritas como portadoras da mutação nt230(del4), incluindo Pastores Alemães (PA). Entretanto, a presença do alelo mutante nessa raça não foi descrita em cães no Brasil. O objetivo desse estudo foi determinar a frequência genotípica e alélica da mutação nt230(del4) em PA no sul do Brasil. Amostras de sangue foram coletadas de 79 PA no estado do Rio Grande do Sul e o genótipo dos cães para o gene MDR1 realizado. Setenta e oito (98.7%) cães foram homozigotos dominantes (selvagem) e um (1.3%) tinha genótipo heterozigoto. A frequência do alelo mutante foi baixa (0.6%), enquanto a frequência do alelo selvagem foi alta (99.4%) nesta população. Este é o primeiro relato da presença desta mutação nt230(del4) no gene MDR1 em PA no Brasil. Esta informação é importante para criadores a fim de prevenir a disseminação do alelo mutante na população de criadores da raça no Brasil e programas internacionais de troca de animais para criação, para tutores e veterinários estarem conscientes quando prescreverem e administrarem medicações para cães PA no Brasil.

Tramadol Effects on Lameness Score After Inhibition of P-GP by Ivermectin Administration in Horses: Preliminary Results.

This study aimed to evaluate the effects and lameness degree in horses administered tramadol after the P-glycoprotein (P-gp) enteric inhibitor ivermectin. Six horses were randomly distributed into three groups, which received two different doses of tramadol by a nasogastric tube: 1 mg/kg (tramadol group 1(GT1)), 4 mg/kg (tramadol group 4 (GT4)), and tramadol 1 mg/kg combined with ivermectin 0.2 mg/kg PO (ivermectin tramadol group (GT1 + Ive)), with one-week washout interval. Heart rate (HR), respiratory rate (RR), intestinal motility, body temperature, and the degree of lameness were evaluated for 360 minutes. The blood gas parameters were evaluated at 0, 60 minutes, and 120 minutes. There were no differences in HR and the degree of lameness. Hypomotility occurred in GT1 and GT4 only at the end of the evaluation period, and RR increased in all groups. We conclude that inhibition of enteric P-gp by ivermectin did not alter the effects of tramadol, suggesting that tramadol is not a substrate for P-gp. However, future studies should be conducted to assess the interaction between P-gp inhibitors on the pharmacokinetics of tramadol.

Subzygomatic and infraorbital approaches for maxillary nerve blockade in cats' cadaver / Abordagens subzigomática e infraorbitária para o bloqueio do nervo maxilar em cadáver de gatos

ABSTRACT: This study compared the accuracy of dye placement on the maxillary nerve by using the percutaneous subzigomatic (SBZ) and infraorbitary (IO) approaches in cats' cadavers. A second aim was to compare the accuracy of dye placement on the maxillary nerve between different untrained anesthetists. This was a prospective, randomized, blinded study, performed in 40 heads obtained from feline cadavers. Three veterinarians (A, B and C) with no previous experience with the IO approach performed the experiments. The SBZ approach was randomly performed on one side of the head and the IO approach was performed in the contralateral side of the same head. For each approach, 0.2ml of 1% methylene blue dye was injected. Scores for length of nerve staining were as follows: 0 (failure), no staining; 1 (moderate), <6mm of nerve stained; and 2 (ideal), ≥6mm of nerve stained. Median scores (interquartile range) for the SBZ and IO approaches were 2.0 (0.3-2.0) and 1.0 (0.0-2.0), respectively. Scores for length of nerve staining were higher with the SBZ approach than the IO approach (P=0.016). Considering the scores for both the SBZ and IO approaches, there was a significant difference among the three veterinarians (P=0.002). Results of this study do not support the IO approach to perform a maxillary nerve block in cats. A greater accuracy of methylene blue dye placement was observed with the SBZ approach. A variable accuracy may exist between different veterinarians when performing a maxillary nerve block employing the SBZ and IO techniques in cats.

RESUMO: O objetivo deste estudo foi comparar o acesso do nervo maxilar pela abordagem subzigomática (SBZ) com a abordagem pelo forame infraorbitário (IO) em peças anatômicas de gatos utilizando o corante azul de metileno. Um segundo objetivo foi comparar a acurácia na coloração do nervo maxilar com o azul de metileno entre diferentes anestesistas que não receberam treinamento prévio. Este estudo foi prospectivo, randomizado, cego, realizado em 40 peças anatômicas de cabeças de gatos. Três veterinários (A, B e C), sem experiência prévia da abordagem IO, realizaram o experimento. A abordagem SBZ foi aleatoriamente realizada em um dos lados da cabeça e a abordagem IO foi realizada no lado contralateral da mesma peça anatômica. Para cada abordagem, utilizou-se 0,2mL do corante azul de metileno 1%. Classificou-se o escore de coloração baseado no comprimento do nervo maxilar corado pelo azul de metileno conforme a escala: 0 (falha da técnica), sem coloração; 1 (moderado), <6mm de coloração do nervo maxilar; 2 (ideal), ≥6mm de coloração do nervo maxilar. As medianas (intervalo interquartil) para as abordagens SBZ e IO (dados de todos os veterinários juntos) foram respectivamente 2,0 (0,3-2,0) e 1,0 (0,0-2,0). A abordagem SBZ foi associada a um escore de coloração, significativamente, maior do que a abordagem IO (P=0,016). Considerando os escores de ambas abordagens (SBZ e IO), houve diferença significativa nos escores de coloração do nervo maxilar entre os três veterinários anestesistas (P=0,002). Os resultados deste estudo não sustentam a utilização da abordagem IO para a realização do bloqueio maxilar em gatos. Uma melhor acurácia na coloração do nervo maxilar com o azul de metileno foi observada com a abordagem SBZ. A acurácia da técnica pode variar quando as abordagens SBZ e IO são realizadas por veterinários diferentes, com o objetivo de se obter o bloqueio do nervo maxilar.

High-resolution melting analysis for detection of a single-nucleotide polymorphism and the genotype of the myostatin gene in warmblood horses.

OBJECTIVE To develop a high-resolution melting (HRM) assay to detect the g.66493737C>T polymorphism in the myostatin gene (MSTN) and determine the frequency of 3 previously defined g.66493737 genotypes (T/T, T/C, and C/C) in warmblood horses. SAMPLES Blood samples from 23 horses. PROCEDURES From each blood sample, DNA was extracted and analyzed by standard PCR methods and an HRM assay to determine the MSTN genotype. Three protocols (standard protocol, protocol in which a high-salt solution was added to the reaction mixture before the first melting cycle, and protocol in which an unlabeled probe was added to the reaction mixture before analysis) for the HRM assay were designed and compared. Genotype results determined by the HRM protocol that generated the most consistent melting curves were compared with those determined by sequencing. RESULTS The HRM protocol in which an unlabeled probe was added to the reaction mixture generated the most consistent melting curves. The genotypes of the g.66493737C>T polymorphism were determined for 22 horses (16 by HRM analysis and 20 by sequencing); 14, 7, and 1 had the T/T, T/C, and C/C genotypes, respectively. The genotype determined by HRM analysis agreed with that determined by sequencing for 14 of 16 horses. The frequency of alleles T and C was 79.5% and 20.5%, respectively. CONCLUSIONS AND CLINICAL RELEVANCE Results indicated that HRM analysis may be a faster and more economical alternative than PCR methods for genotyping. Genotyping results might be useful as predictors of athletic performance for horses.

Ruptura de cornos uterinos decorrente de piometra – relato de caso / Uterine corpus rupture decorrente of pyometra – case report

A piometra canina pode ser conhecida também como hiperplasia endometrial cística, sendo mais comum em cães na fase adulta da vida, caracterizado com a inflamação do útero e acúmulo de pus (VOLPATO et al., 2012). Geralmente, está relacionada às alterações hormonais e é comumente observada em cães idosos ou de meia-idade (SHIA et al., 2011). O acúmulo de substância purulenta dentro do lúmen do útero de cadelas ocorre comumente durante ou posterior a uma temporada de predominância da progesterona, que age estimulando a secreção das glândulas do endométrio, eliminando as contrações do útero, criando assim um ambiente intra-uterino benéfico para o crescimento bacteriano (PATIL et al., 2013).